Stay updated on Ad-p53+Xeloda/Anti-PD-1 Safety/Efficacy in Liver Metastases Clinical Trial

Sign up to get notified when there's something new on the Ad-p53+Xeloda/Anti-PD-1 Safety/Efficacy in Liver Metastases Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Ad-p53+Xeloda/Anti-PD-1 Safety/Efficacy in Liver Metastases Clinical Trial page

  1. Check
    7 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov error page footer now shows revision v3.7.2 instead of v3.7.1.
    Difference
    0.2%
    Check dated 2026-10-18T15:30:47.000Z thumbnail image
  2. Check
    14 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov footer revision identifier changes from v3.7.0 to v3.7.1; the page continues to show a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-11T15:23:20.000Z thumbnail image
  3. Check
    21 days ago
    No Change Detected
  4. Check
    35 days ago
    Change Detected
    Summary
    The page now shows a 403 Forbidden error with a standard header, replacing the study record content and indicating that the study details are currently inaccessible.
    Difference
    21%
    Check dated 2026-09-20T16:09:21.000Z thumbnail image
  5. Check
    56 days ago
    Change Detected
    Summary
    Revision tag updated from v3.6.5 to v3.6.6 on the page, indicating a minor site revision rather than changes to the study details.
    Difference
    0.1%
    Check dated 2026-08-30T15:25:29.000Z thumbnail image
  6. Check
    77 days ago
    Change Detected
    Summary
    The page footer revision label was updated from v3.6.4 to v3.6.5, reflecting a minor update to the page version.
    Difference
    0.1%
    Check dated 2026-08-09T15:25:45.000Z thumbnail image
  7. Check
    84 days ago
    Change Detected
    Summary
    The page footer revision was updated from v3.6.3 to v3.6.4, signaling a minor site maintenance update. This change does not modify the study content or how information is presented.
    Difference
    0.1%
    Check dated 2026-08-02T15:00:35.000Z thumbnail image

Stay in the know with updates to Ad-p53+Xeloda/Anti-PD-1 Safety/Efficacy in Liver Metastases Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Ad-p53+Xeloda/Anti-PD-1 Safety/Efficacy in Liver Metastases Clinical Trial page.